Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • New2Bioinfo
    Junior Member
    • Dec 2016
    • 4

    #1

    Indexing- Exons and splice sites

    Hi,
    I have been following the github tutorial, https://github.com/griffithlab/rnaseq_tutorial/wiki

    to learn RNAseq.

    I was on the indexing step and it says to first export exons and splice sites from reference genome using in-built python scripts before starting the indexing. And then that this information will be used during alignment.

    It would be great if someone could explain the rationale behind this step.
    ----
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Sometimes if you are happy with the current state of the transcriptome (known expressed parts of the genome) then you could choose to do alignments of your data just to that part.

    While that is not incorrect, you do run a small risk of having some reads mis-align (since an aligner does its best to align and the read may not have originally come from that region) by restricting to just "known" expressed parts of the genome. If splice sites are provided as well then the programs would not try to look for new ones. Both these modifications speed up the alignments to some extent.

    Comment

    • New2Bioinfo
      Junior Member
      • Dec 2016
      • 4

      #3
      Originally posted by GenoMax View Post
      Both these modifications speed up the alignments to some extent.
      That's okay. But while using the HISAT2 program, I am extracting the splice site and exon information from the .gtf file. And that information is given to the index builder (Hisat2-build). So, what I am getting is that this information during indexing is helping during alignment.

      If I know the splice sites, the reads will not align to those parts where splice sites lie in the middle. Is this correct?
      I still don't get how exon info is helping in alignment.

      A little more detailed answer would be really really helpful.

      Thank you.
      ----

      Comment

      • wdecoster
        Member
        • Oct 2015
        • 97

        #4
        The most intuitive explanation might be that those "known" exons and splice sites are used as a suggestion for the read mapping, making mapping much quicker since the aligner "knows" where to look. Reads that don't behave according to the "known" annotation will still get correctly aligned and new splice sites will be discovered.

        You are just "telling" the aligner a priori where the splice junctions most likely are (but not restricting the mapping to those junctions/exons).

        Comment

        • New2Bioinfo
          Junior Member
          • Dec 2016
          • 4

          #5
          Okay. That makes sense.

          Thank you very much.
          ----

          Comment

          • biocomputer
            Member
            • Dec 2013
            • 62

            #6
            Does including exons and splice sites make the alignment more accurate, faster, or both?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            29 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            39 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            45 views
            0 reactions
            Last Post SEQadmin2  
            Working...